Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$9.97

-0.52 (-4.96%)

07:22
10/12/18
10/12
07:22
10/12/18
07:22

Iovance Biotherapeutics price target raised to $25 from $22 at Oppenheimer

Oppenheimer analyst Mark Breidenbach reiterated an Outperform rating on Iovance Biotherapeutics and raised his price target to $25 from $22 citing recent positive clinical updates for its tumor infiltrating lymphocyte product for melanoma and the outcome of discussions with the FDA regarding the regulatory pathway forward.

  • 19

    Oct

  • 12

    Oct

IOVA Iovance Biotherapeutics
$9.97

-0.52 (-4.96%)

09/06/18
OPCO
09/06/18
NO CHANGE
Target $22
OPCO
Outperform
Iovance down after Moffitt data, Oppenheimer reiterates Outperform rating
Preliminary clinical data from a Moffitt-sponsored trial of tumor infiltrating lymphocyte therapy in lung cancer was published yesterday in an abstract, Oppenheimer analyst Mark Breidenbach tells investors in a research note. Per the abstract, two of six efficacy-evaluable patients achieved partial responses of limited duration, Breidenbach points out. While these data suggest tumor infiltrating lymphocyte therapy is active in non-small-cell lung carcinoma, the limited durability of response suggests an optimal strategy for generating and deploying TIL in NSCLC has yet to be worked out, contends the analyst. His thesis on Iovance Biotherapeutics remains focused on melanoma and HPV-associated cancers. Breidenbach reiterates an Outperform rating on Iovance with a $22 price target. The stock in early trading is down 10.5%, or $1.78, to $15.18.
09/06/18
RILY
09/06/18
NO CHANGE
Target $24
RILY
Buy
Moffitt data has little read-across to Iovance platform, says B. Riley FBR
Preliminary clinical data from a Moffitt-sponsored trial of tumor infiltrating lymphocyte therapy in lung cancer has little read-across to Iovance Biotherapeutics' TIL platform, B. Riley FBR analyst Madhu Kumar tells investors in a research note. He reiterates a Buy rating on Iovance with a $24 price target. The stock in morning trading is down 13%, or $2.25, to $14.70.
09/13/18
JEFF
09/13/18
NO CHANGE
Target $31
JEFF
Buy
Feedback on Moffitt TIL study appears positive, says Jefferies
Jefferies analyst Biren Amin hosted a call with an oncologist at Moffitt Cancer Center to review the initial data from this first non-small cell lung cancer tumor infiltrating lymphocytes study. The doctor highlighted the large unmet need in NSCLC patients who failed to respond to anti-PD-1 therapy and feels the 100% disease control rate achieved in the first eight refractory patients to nivo is promising, Amin tells investors in a research note. Further, the oncologist believes the limited duration of response could improve in a second NSCLC study incorporating key "biomarkers," the analyst points out. Amin believes Iovance Biotherapeutics could incorporate some of these key learnings into its two Phase I/II NSCLC studies. The analyst keeps a Buy rating on Iovance with a $31 price target.
09/25/18
COWN
09/25/18
NO CHANGE
COWN
Outperform
Iovance Biotherapeutics weakness a buying opportunity, says Cowen
Cowen analyst Boris Peaker said the recent weakness in Iovance is a buying opportunity. The analyst noted the company's results from the Moffitt-run study of TILS in NSCLC were deemed mild and somewhat disappointing. He believes the data has no read-through to the ongoing melanoma trial, making the weakness an attractive entry point. Peaker reiterated his Outperform rating on Iovance shares.

TODAY'S FREE FLY STORIES

03:00
10/17/18
10/17
03:00
10/17/18
03:00
General news
FX Action: USD-CAD has recouped to around 1.2950 »

FX Action: USD-CAD has…

02:15
10/17/18
10/17
02:15
10/17/18
02:15
General news
FX Update: The Dollar majors continue to lack direction »

FX Update: The Dollar…

01:40
10/17/18
10/17
01:40
10/17/18
01:40
General news
FX Action: USD-JPY posted a three-session high »

FX Action: USD-JPY posted…

SIBN

SI-BONE

$0.00

(0.00%)

20:54
10/16/18
10/16
20:54
10/16/18
20:54
Syndicate
SI-BONE 7.2M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AMX

America Movil, also tag AMOV

$15.77

0.38 (2.47%)

, AMOV

America Movil, also tag AMX

$15.03

(0.00%)

20:44
10/16/18
10/16
20:44
10/16/18
20:44
Earnings
America Movil reports Q3 net income MXN18.96B vs. MXN2.52B last year »

Reports Q3 revenue…

AMX

America Movil, also tag AMOV

$15.77

0.38 (2.47%)

AMOV

America Movil, also tag AMX

$15.03

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$70.94

2.22 (3.23%)

, USB

U.S. Bancorp

$50.97

0.44 (0.87%)

20:25
10/16/18
10/16
20:25
10/16/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$70.94

2.22 (3.23%)

USB

U.S. Bancorp

$50.97

0.44 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

ADTN

Adtran

$18.15

1.08 (6.33%)

20:24
10/16/18
10/16
20:24
10/16/18
20:24
Earnings
Adtran reports Q3 adjusted EPS 21c, consensus 4c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

WAFD

Washington Federal

$29.75

0.45 (1.54%)

20:02
10/16/18
10/16
20:02
10/16/18
20:02
Earnings
Washington Federal reports Q4 EPS 62c, consensus 62c »

Reports Q4 NII $124.8M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

UNH

UnitedHealth

$272.24

12.44 (4.79%)

19:30
10/16/18
10/16
19:30
10/16/18
19:30
Recommendations
UnitedHealth analyst commentary at Piper Jaffray »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

CDAY

Ceridian

$38.44

1.38 (3.72%)

19:25
10/16/18
10/16
19:25
10/16/18
19:25
Conference/Events
Ceridian to hold a conference »

INSIGHTS 2018 will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HMC

Honda

$27.70

0.65 (2.40%)

19:07
10/16/18
10/16
19:07
10/16/18
19:07
Periodicals
Honda Aircraft sees higher light jet deliveries next year, Reuters says »

Honda Aircraft co-CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

VALE

Vale

$15.50

0.045 (0.29%)

18:59
10/16/18
10/16
18:59
10/16/18
18:59
Periodicals
Vale plans to use cash flow cautiously going forward, Reuters says »

Vale said it intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICR

Vicor Corporation

$38.35

1.42 (3.85%)

, NFLX

Netflix

$346.40

13.29 (3.99%)

18:55
10/16/18
10/16
18:55
10/16/18
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Vicor…

VICR

Vicor Corporation

$38.35

1.42 (3.85%)

NFLX

Netflix

$346.40

13.29 (3.99%)

LRCX

Lam Research

$145.33

2.72 (1.91%)

AMAT

Applied Materials

$34.76

1.33 (3.98%)

UAL

United Continental

$83.51

2.17 (2.67%)

FULT

Fulton Financial

$16.39

0.29 (1.80%)

CSX

CSX

$72.15

1.29 (1.82%)

CREE

Cree

$37.56

2.53 (7.22%)

ROKU

Roku

$63.67

1.97 (3.19%)

IBM

IBM

$145.02

3.9 (2.76%)

UFPI

Universal Forest

$34.08

1.27 (3.87%)

SONC

Sonic

$43.27

-0.03 (-0.07%)

EIGR

Eiger BioPharmaceuticals

$10.88

0.63 (6.15%)

SBH

Sally Beauty

$18.91

0.42 (2.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 06

    Nov

  • 13

    Nov

  • 27

    Nov

  • 12

    Dec

  • 13

    Dec

  • 03

    Mar

NFLX

Netflix

$346.40

13.29 (3.99%)

18:38
10/16/18
10/16
18:38
10/16/18
18:38
Hot Stocks
Netflix says it has a 'long, long runway' in India »

Chief Product Officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

CBL

CBL & Associates

$3.52

0.085 (2.48%)

, SHLD

Sears

$0.40

0.09 (29.03%)

18:33
10/16/18
10/16
18:33
10/16/18
18:33
Hot Stocks
CBL Properties updates on redevelopment plan for Sears stores »

CBL Properties (CBL)…

CBL

CBL & Associates

$3.52

0.085 (2.48%)

SHLD

Sears

$0.40

0.09 (29.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

VZ

Verizon

$53.68

0.08 (0.15%)

18:26
10/16/18
10/16
18:26
10/16/18
18:26
Hot Stocks
Verizon says Bay, Gulf counties customers to be credited 3 months of service »

Verizon said that it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

BMO

Bank of Montreal

$80.19

0.93 (1.17%)

18:09
10/16/18
10/16
18:09
10/16/18
18:09
Periodicals
Bank of Montreal names Wolford investment banking vice chair, Reuters says »

Bank of Montreal has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

SFTBF

SoftBank

$0.00

(0.00%)

18:02
10/16/18
10/16
18:02
10/16/18
18:02
Periodicals
SoftBank COO says 'anxiously' looking at Saudi Arabia situation, Reuters says »

SoftBank COO Marcelo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

IBM

IBM

$145.02

3.9 (2.76%)

18:01
10/16/18
10/16
18:01
10/16/18
18:01
Hot Stocks
IBM sees growth in cloud overall »

Says incremental cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

CELC

Celcuity

$26.90

0.4 (1.51%)

, PBYI

Puma Biotechnology

$42.22

1.17 (2.85%)

17:57
10/16/18
10/16
17:57
10/16/18
17:57
Hot Stocks
Celcuity, Puma Biotechnology and West Cancer Center to conduct Phase 2 trial »

Celcuity (CELC) announced…

CELC

Celcuity

$26.90

0.4 (1.51%)

PBYI

Puma Biotechnology

$42.22

1.17 (2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 15

    Nov

DVN

Devon Energy

$37.08

0.98 (2.71%)

17:51
10/16/18
10/16
17:51
10/16/18
17:51
Recommendations
Devon Energy analyst commentary at MUFG »

Devon Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$36.07

1.11 (3.18%)

, VIAB

Viacom

$32.83

1.05 (3.30%)

17:51
10/16/18
10/16
17:51
10/16/18
17:51
Periodicals
Viacom launches Nickelodeon Chinese Animation Development Project, Variety says »

According to Variety,…

VIA

Viacom

$36.07

1.11 (3.18%)

VIAB

Viacom

$32.83

1.05 (3.30%)

IQ

iQIYI

$25.91

-0.19 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BHP

BHP Billiton

$48.48

0.38 (0.79%)

17:38
10/16/18
10/16
17:38
10/16/18
17:38
Hot Stocks
BHP Billiton reports Q1 iron ore output 61.4M tons, up 10% from last year »

FY19 guidance for iron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

17:37
10/16/18
10/16
17:37
10/16/18
17:37
Periodicals
Uber increases junk-bond offering to $2B, Bloomberg says »

Uber has boosted the size…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$145.02

3.9 (2.76%)

17:32
10/16/18
10/16
17:32
10/16/18
17:32
Hot Stocks
IBM says growth was led by hybrid cloud, analytics and AI, digital and security »

Says remains on track…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.